A phase I trial of weekly gemcitabine administered as a prolonged infusion in patients with pancreatic cancer and other solid tumors.
about
A phase II trial of prolonged, continuous infusion of low-dose gemcitabine plus cisplatin in patients with advanced malignant pleural mesothelioma.Phase I/II trial of GN-BVC, a gemcitabine and vinorelbine-containing conditioning regimen for autologous hematopoietic cell transplantation in recurrent and refractory hodgkin lymphomaBreast Cancer Systemic Therapy: The Need for More Economically Sustainable Scientific Strategies in the World.A Multi-institutional Phase 2 Study of Imatinib Mesylate and Gemcitabine for First-Line Treatment of Advanced Pancreatic CancerGemcitabine and acute myocardial infarction--a case report.Phase I/II trial of doxorubicin and fixed dose-rate infusion gemcitabine in advanced soft tissue sarcomas: a GEIS study.Prolonged fixed dose rate infusion of gemcitabine with autologous haemopoietic support in advanced pancreatic adenocarcinoma.Prospective randomised phase II study of gemcitabine at standard or fixed dose rate schedule in unresectable hepatocellular carcinoma.Overcoming nucleoside analog chemoresistance of pancreatic cancer: a therapeutic challenge.Phase I clinical trial of fixed-dose rate infusional gemcitabine and dacarbazine in the treatment of advanced soft tissue sarcoma, with assessment of gemcitabine triphosphate accumulation.Safety assessment of 4'-thio-beta-D-arabinofuranosylcytosine in the beagle dog suggests a drug-induced centrally mediated effect on the hypothalamic-pituitary-adrenal axis.
P2860
Q33414357-7AF86D2B-3D2D-4910-B622-BC7B20A97783Q34064220-C6CA4621-64C5-4768-8515-E3D2E3609BEDQ34095977-CE640C81-EA60-44EC-A5B2-6A1636A1E2ABQ36153450-73B51B90-91A7-4DB5-8E8A-BEE7B1591B9FQ36480065-03604136-AA86-4914-8198-CC3B5E850ECCQ36614418-BAADDD88-FEDB-4689-8909-51AB42E619C0Q36614865-A68AC699-EE0E-4C7A-9BF1-16885224F8B5Q36671639-1BF33B2D-34E8-4374-9D2F-C7E8A2BB39A6Q37994505-29DB9D6E-BF76-4685-A269-7A835132BF25Q40523631-75452731-8A30-403E-82B8-F01245C6B4CEQ48592569-A5CDA566-A53A-4327-8F90-63FE7BD00C23
P2860
A phase I trial of weekly gemcitabine administered as a prolonged infusion in patients with pancreatic cancer and other solid tumors.
description
1997 nî lūn-bûn
@nan
1997 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
A phase I trial of weekly gemc ...... cancer and other solid tumors.
@ast
A phase I trial of weekly gemc ...... cancer and other solid tumors.
@en
type
label
A phase I trial of weekly gemc ...... cancer and other solid tumors.
@ast
A phase I trial of weekly gemc ...... cancer and other solid tumors.
@en
prefLabel
A phase I trial of weekly gemc ...... cancer and other solid tumors.
@ast
A phase I trial of weekly gemc ...... cancer and other solid tumors.
@en
P2093
P356
P1476
A phase I trial of weekly gemc ...... cancer and other solid tumors.
@en
P2093
P2888
P304
P356
10.1023/A:1005981317532
P577
1997-01-01T00:00:00Z
P6179
1018796264